Elevance Health Dividenden en inkoop
Dividend criteriumcontroles 4/6
Elevance Health is een dividendbetalend bedrijf met een huidig rendement van 1.53% dat ruimschoots wordt gedekt door de winst. Volgende betalingsdatum is op 20th December, 2024 met een ex-dividenddatum van 5th December, 2024.
Belangrijke informatie
1.5%
Dividendrendement
1.9%
Terugkoop Rendement
| Totaal aandeelhoudersrendement | 3.4% |
| Toekomstig dividendrendement | 1.7% |
| Dividendgroei | -3.7% |
| Volgende betaaldatum dividend | 20 Dec 24 |
| Ex-dividenddatum | 05 Dec 24 |
| Dividend per aandeel | US$6.520 |
| Uitbetalingsratio | 23% |
Recente updates van dividend en inkoop
Recent updates
We Think Elevance Health's (NYSE:ELV) Profit Is Only A Baseline For What They Can Achieve
Oct 29
Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds
Oct 17Elevance: Our Top Value Pick Trading At 12.5x Earnings And Growing At 12.5%
Oct 10Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Oct 08Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)
Sep 11Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth
Sep 06There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital
Aug 29Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching
Aug 02Elevance Health: Healthcare Services Segment Is Gaining Traction
Jul 31Elevance Health: Buy A Dividend Growth Machine
Jul 18Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)
Jun 28Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
May 27We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation
May 09Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63
Apr 25Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors
Apr 01Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63
Feb 19Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement
Jan 19Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story
Dec 18A Look At Elevance's Margin Dynamics
Nov 23Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?
Nov 16Elevance Health: A High Conviction Defensive Blue Chip Buy
Oct 19These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Elevance: Pave The Way For The Next UnitedHealth
Sep 21Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Sep 18Here's The Price I Would Buy Elevance Health Stock
Sep 13If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity
Aug 18Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
Aug 04Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental
Jul 24Elevance Health: Beaten Down Share Price Offers Solid Potential
Jul 10Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05Elevance Health: A Critical Update (Rating Downgrade)
Jun 05Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
Jun 04Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
May 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Komende dividendbetaling
Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Het dividend per aandeel van ELV is de afgelopen 10 jaar stabiel gebleven.
Groeiend dividend: De dividendbetalingen van ELV zijn de afgelopen 10 jaar gestegen.
Dividendrendement versus markt
| Elevance Health Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (ELV) | 1.5% |
| Markt onderkant 25% (US) | 1.3% |
| Markt Top 25% (US) | 4.3% |
| Gemiddelde industrie (Healthcare) | 1.6% |
| Analist prognose (ELV) (tot 3 jaar) | 1.7% |
Opmerkelijk dividend: Het dividend van ELV ( 1.53% ) is hoger dan dat van de onderste 25% van de dividendbetalers op de US markt ( 1.34% ).
Hoog dividend: Het dividend ELV ( 1.53% ) is laag vergeleken met de top 25% van dividendbetalers in de US markt ( 4.31% ).
Winstuitkering aan aandeelhouders
Verdiendekking: Met zijn lage payout ratio ( 23.1% ) worden de dividendbetalingen van ELV ruimschoots gedekt door de winst.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Gezien de hoge cash payout ratio ( 173.6% ) worden de dividendbetalingen van ELV niet goed gedekt door de kasstromen.